Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Arterial Revascularisation Trial - A randomised trial to compare survival following bilateral versus single internal mammary artery (IMA) grafting in coronary revascularisation
ISRCTN ISRCTN46552265
ClinicalTrials.gov identifier
Public title Arterial Revascularisation Trial - A randomised trial to compare survival following bilateral versus single internal mammary artery (IMA) grafting in coronary revascularisation
Scientific title
Acronym ART
Serial number at source G0200390
Study hypothesis The main objective is to assess whether the use of both IMA during coronary artery bypass graft (CABG) surgery improves survival and reduces the need for further interventions over that observed with a single IMA.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Australia, Brazil, Poland, United Kingdom, Europe
Disease/condition/study domain Cardiovascular
Participants - inclusion criteria Coronary artery bypass graft (CABG) patients with multi-vessel coronary artery disease (including urgent and off pump CABG patients)
Participants - exclusion criteria 1. Single graft
2. Redo CABG
3. Evolving myocardial infarction
4. Concomitant valve surgery
Anticipated start date 01/07/2004
Anticipated end date 30/06/2014
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 3000
Interventions Patients will be randomised to single internal mammary artery (SIMA) grafting or bilateral internal mammary artery (BIMA) grafting with supplemental vein or radial artery grafts as required.
Primary outcome measure(s) Survival
Secondary outcome measure(s) 1. Cause-specific mortality
2. 30 day mortality
3. Need for re-intervention by percutaneous coronary intervention or redo surgery
other clinical events
4. Quality of Life Evaluation (SF36, Rose and EuroQol)
5. Cost-effectiveness
Sources of funding ART is funded jointly by a grant from the British Heart Foundation (UK) (SP/03/001) and a grant from the Medical Research Council (UK) (G0200390)
Trial website http://www.herc.ox.ac.uk/research/evaluations/art
Publications 1. 2006 protocol in http://www.ncbi.nlm.nih.gov/pubmed/16573820
2. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20805116
3. 2011 assessment of data quality in http://www.ncbi.nlm.nih.gov/pubmed/21943128
Contact name Mr  David  Taggart
  Address Department of Cardiothoracic Surgery
The John Radcliffe
Headley Way
Headington
  City/town Oxford
  Zip/Postcode OX3 9DU
  Country United Kingdom
Sponsor University of Oxford (UK)
  Address University Offices
Wellington Square
  City/town Oxford
  Zip/Postcode OX1 2JD
  Country United Kingdom
  Sponsor website: http://www.ox.ac.uk
Date applied 19/10/2004
Last edited 07/02/2012
Date ISRCTN assigned 17/01/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central